Esophageal cancer pathophysiology: Difference between revisions
Jump to navigation
Jump to search
(Created page with "{{Esophageal cancer}} {{CMG}} ==Overview== ==References== {{reflist|2}} Category:Disease Category:Types of cancer Category:Gastroenterology [[Category:Oncology...") |
|||
Line 3: | Line 3: | ||
==Overview== | ==Overview== | ||
==Pathophysiology== | |||
====Microscopic pathology==== | |||
Most tumors of the esophagus are malignant. A very small proportion (under 10%) is [[leiomyoma]] (smooth muscle tumor) or [[gastrointestinal stromal tumor]] (GIST). Malignant tumors are generally [[adenocarcinoma]]s, [[squamous cell carcinoma]]s, and occasionally ''small-cell carcinomas''. The latter share many properties with small-cell [[lung cancer]], and are relatively sensitive to chemotherapy compared to the other types. | |||
==References== | ==References== |
Revision as of 21:34, 18 January 2012
Esophageal cancer Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Esophageal cancer pathophysiology On the Web |
American Roentgen Ray Society Images of Esophageal cancer pathophysiology |
Risk calculators and risk factors for Esophageal cancer pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Pathophysiology
Microscopic pathology
Most tumors of the esophagus are malignant. A very small proportion (under 10%) is leiomyoma (smooth muscle tumor) or gastrointestinal stromal tumor (GIST). Malignant tumors are generally adenocarcinomas, squamous cell carcinomas, and occasionally small-cell carcinomas. The latter share many properties with small-cell lung cancer, and are relatively sensitive to chemotherapy compared to the other types.